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Abstract: 
Nitrogen gases are used at different stages of the pharmaceutical manufacturing process for several applications. 
Nitrogen gas sampling for microorganisms plays vital part in the contamination control. The aim of the work was to 
evaluate the aerobic and anaerobic microbial count in nitrogen gas during drug manufacturing process. The 
Nitrogen samples were collected at two different sites about 1000 liters of air sampled by using M-Air- T air sampler 
and petri plates containing soya bean casein digest agar used for sampling.  The processed plates were incubated for 
aerobic microbial count at 20-25° C for 3 days for fungal count, followed by 30-35° C for 3-5 days for bacterial 
count. Incubated anaerobic microbial count at 30-35°C for 3 days using anaerobic jar and anaerobic gas pack. After 
incubation the plates were evaluated for microbial count. The results observed during the study met the acceptance 
limits as per the ISPE guideline, the microbial count for non-sterile applications limit is to be established based on 
the product bioburden limits. Typical level NMT 5 cfu/m3 and for sterile applications as per the viable particle 
requirements for grade area where the product is exposed to the compressed gas (eg.Grade A, Grade A/B, Grade B 
or Grade C). The pharmaceutical manufacturing industries are supposed to set up the limit and acceptance criteria 
based on the periodic evaluation. 
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INTRODUCTION: 
Nitrogen gas plays a significant role in the 
pharmaceutical industry, with a broad range of 
applications such as transfer, purging, blanketing, 
drug manufacturing, aseptic packaging, analytical 
testing, filtration, separation and purification [7]. 
Nitrogen gas is an inert gas, which protect from 
aerobic microbial contamination in the manufactured 
drug and increase their shelf life of drug.  The 
presence of aerobic and anaerobic microorganisms in 
nonsterile and sterile preparations may have the 
potential to decrease or inactivate the therapeutic 
activity of the drug and which in turn adversely affect 
the health of the patient [10]. 
 
Aerobic bacterium is an organism which can survive 
and grow in an oxygenated environment. Anaerobic 
bacteria are organisms that are capable of surviving 
and growing in an atmosphere presence of little or no 
oxygen. Anaerobic bacteria can be further classified 
based their relationship to oxygen obligate, 
aerotolerant or facultative anaerobes. Aerobic and 
anaerobic are found in a variety of environments 
ranging from soil, water, humans and animals [4].  
 
Various methods have been stated for the assessment 
of Nitrogen gas analysis for microbial contamination 
using M-Air-T sampler (Millipore), Active air 
sampler and using purging in sterile liquid media and 
test by filtration technique. In recent years, M-Air-T 
sampler / Active air sampler   have been developed to 
evaluate the microbial count from compressed gas 
monitoring. In the present study, M-Air-T sampler 
has been adopted to evaluate the microbial 
contamination in nitrogen gas. 
 
The present work aim was to evaluate the aerobic and 
anaerobic microbial count in nitrogen gas during drug 
manufacturing process. Rationale behind the work 
was, to control aerobic and anaerobic microbial count 
throughout manufacturing process.    
 
MATERIALS AND METHODS: 
Chemicals and reagents 
Pre-incubated Soyabean casein digest agar were 
supplied by Himedia. Culture Staphylococcus aureus 
ATCC 6538 Pseudomonas aeruginosa ATCC 9027 
Escherichia coli ATCC 8739 Candida albicans 
ATCC 10231 Aspergillus niger ATCC 16404, 
Clostridium sporogens ATCC19404 obtained from 
American type culture collection (ATCC). Anaerogas 
pack and indicator obtained from Himedia. 
  
 
 
 
Instrumentation 
M Air T (Air sampler) Millipore, Incubators make 
Thermolab, autoclave makes machine fabric, laminar 
airflow unit make Esco,  
 
Preparation of Plates: 
Prepared Soya bean Casein Digest Agar plates for 
aerobic microbial count and anaerobic microbial 
count. The media plates were subjected for growth 
promotion test with above mentioned culture aerobic 
and anaerobic condition. 
 
Transfer of Plates to the Area: 
Covered the plates with aluminum foil in a stack of 
10 plates and placed the plates in the plate carrier 
stand.   Transferred the plates to respective areas. 
After sample collection the plates are again wrapped 
the plates with aluminum foil and transferred the 
plates back to the laboratory. Unwrapped and 
incubated the plates in the anaerobic jar. 
 
Sample Location and Collection:  
Sample has been collected from generation point and 
user point. 
 
Nitrogen Gas Sampling: 
Sampler head and connection tubes were sterilized at 
121°C for 30minuts. Transfer all the required 
material to the sampling location.  Opened sampler 
head and place media cassette and placed pressure 
reducer and connected to sampling port, 1000 litre of 
Air Sampled M-Air- T air sampler make 
Millipore[11]. The sample inlet is connected to the 
nitrogen gas line and air is directed over an agar 
plate. The method works by compressed gas under 
reduced pressure (called “partial flow”) is forced over 
the surface of an agar plate.  The micro-organisms, 
due to their weight, are flung into the agar surface, 
whereas the air molecules are deflected. 
Appropriately incubated, they grow into colonies, 
which are counted on the assumption that one 
microorganism gives rise to one colony [5]. 
 
The sampling time should be sufficient in order to 
sample one cubic meter of the agar. After sampling, 
the agar plate is removed and incubated within a 
microbiology laboratory. At the end of incubation, the 
agar is examined for colony forming units. If colony 
forming units are recovered, these should be assessed 
against the appropriate limit. It is good practice to 
identify the contaminants recovered; the identification 
may provide important information to help determine 
the origin of the micro flora [9]. 
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The approaches identify a risk, rate the level of the 
risk, and then develop a plan to reduce, control, and 
monitor the risk. For example, the monitoring of the 
risk will help to regulate the occurrence, locations, and 
level for environmental monitoring [6]. 
 
Negative Control of Environmental Monitoring 
Petri Plates: 
The pre-incubated Soya bean casein digest agar plates 
of the same lot shall be carried out all the way and 
incubated along with the sampled media plates as a 
negative control. 
 
Incubation: 
The processed plates were transferred to microbiology 
department and incubated for aerobic microbial count 
at 20-25° C for 3 days fungal count, followed by 30-
35° C for 3-5 days for bacterial count [8]. Incubated 
anaerobic microbial count at 30-35°C for 3 days 
aerobic and anaerobic condition separately. After 
incubation the plates were removed from the incubator 
to process the recording the result. 
 
RESULTS: 
The nitrogen sampling study performed for one year 
in the one month frequency to cover entire seasonal 
changes. However one month data has been tabulated 
and <1cfu/ m3 counts were observed in Fungal count, 
Aerobic microbial count for bacteria and anaerobic 
microbial count. The data’s are presented in the Table 
1 and Table 2.  
 
Table 1: Aerobic and Anaerobic Microbial Count of Nitrogen Sampling (Site 1) 
 
S. No 
Date of 
sampling 
Sampling point 
Fungal 
count 
Aerobic microbial 
count (Bacterial 
count) 
Anaerobic 
microbial 
count 
1 14/04/2015 NA – 01 (Generation point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
2 14/04/2015 NA-02 (User point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
3 14/04/2015 NA-03 (User point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
4 14/04/2015 NA-04 (User point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
5 14/04/2015 NA-05 (User point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
6 14/04/2015 NA-06 (User point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
7 14/04/2015 NA-07 (User point) < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
 
 
Table 2: Aerobic and Anaerobic Microbial Count of Nitrogen Sampling (Site 2) 
 
S. No 
Date of 
sampling 
Sampling point Fungal count 
Aerobic microbial 
count (Bacterial 
count) 
Anaerobic 
microbial 
count 
1 22/11/2015 PRS P – II, Nitrogen  Outlet < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
2 22/11/2015 RVD - 301 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
3 22/11/2015 RVD - 302 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
4 22/11/2015 RVD - 303 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
5 22/11/2015 N2 Generation - Utility < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
6 22/11/2015 ANF - 301 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
7 22/11/2015 ANF - 302 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
8 22/11/2015 ANF - 303 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
9 22/11/2015 CF-201 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
10 22/11/2015 CF-202 < 1 cfu /m3 < 1 cfu /m3 < 1 cfu /m3 
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DISCUSSION: 
During the one year evaluation of nitrogen sampling in 
drug manufacturing process the Aerobic and 
Anaerobic Microbial Count in site 1 and 2 no growths 
were observed. 
 
Sterility is achieved through the use of a bacterial 
retentive membrane filter (0.2 µm pore size) [7]. A 
sterile-filtered gas is required where a gas contacts a 
sterilized component or material. It is important that 
the sterilizing grade filter is maintained dry for 
condensate in a gas filter will most probably cause 
blockage or lead to microbial contamination. Risks of 
condensate are controlled by heating and use of 
hydrophobic filters (to prevent moisture residues in a 
gas supply system) [2]. 
 
All product get in touch with nitrogen gases should be 
assessed aerobic and anaerobic microbial 
contamination. A sampling plan should consider and 
adapt to increased or reduced production schedules, 
seasonal changes, equipment changes and 
modifications, replacement of hardware or filters. 
 
AS per the ISPE Good Practice Guide - Process Gases, 
the microbial count for non-sterile applications limit is 
to be established based on the product bioburden 
limits. Typical level NMT 5 cfu/m3 [4] and for sterile 
applications as per the viable particle requirements for 
grade area where the product is exposed to the 
compressed gas (eg.Grade A, Grade A/B, Grade B or 
Grade C) for aerobic microbial count. The result 
during the above mentioned study met the acceptance 
limits as per the ISPE guideline requirement [3].        
 
CONCLUSION: 
The assessment of nitrogen gas is an important part of 
quality control within pharmaceutical organizations 
whether that assessment is for chemical impurities, 
particulates, or microorganisms [7]. This paper has 
assessed the appropriate standards for nitrogen gas 
focused on microbiological sampling. In doing so, the 
important features of air sampling have been raised 
together with the factors that can lead to microbial 
contamination occurring. These aspects should be built 
into a biocontamination control program. The 
pharmaceutical manufacturing industries should 
establish the limit and acceptance criteria based on the 
trend. 
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